The U.S. plasmid DNA contract manufacturing market is expanding rapidly due to the increasing development of gene therapies, DNA-based vaccines, and advanced biologics. The presence of leading biotechnology companies, strong research infrastructure, and rising demand for outsourced manufacturing services are driving market growth. Growing investments in cell and gene therapy development are...